The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

R Lazarus; S Baos; H Cappel-Porter; A Carson-Stevens; MC Clout; L Culliford; SR Emmett; J Garstang; L Gbadamoshi; B Hallis; RA Harris; D Hutton; CT Group

doi:10.2139/ssrn.3931758

The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

R Lazarus, S Baos, H Cappel-Porter, A Carson-Stevens, MC Clout, L Culliford, SR Emmett, J Garstang, L Gbadamoshi, B Hallis, RA Harris, D Hutton, CT Group

Research output: Other contribution

Original language	Undefined/Unknown
DOIs	https://doi.org/10.2139/ssrn.3931758
Publication status	Published - Sept 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2139/ssrn.3931758

Handle.net

Persistent link

Cite this

Lazarus, R., Baos, S., Cappel-Porter, H., Carson-Stevens, A., Clout, MC., Culliford, L., Emmett, SR., Garstang, J., Gbadamoshi, L., Hallis, B., Harris, RA., Hutton, D., & Group, CT. (2021, Sept). The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV). https://doi.org/10.2139/ssrn.3931758

@misc{077baeb5f1c34e5893365fb4a1f17c24,

title = "The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)",

author = "R Lazarus and S Baos and H Cappel-Porter and A Carson-Stevens and MC Clout and L Culliford and SR Emmett and J Garstang and L Gbadamoshi and B Hallis and RA Harris and D Hutton and CT Group",

year = "2021",

month = sep,

doi = "10.2139/ssrn.3931758",

language = "Undefined/Unknown",

type = "Other",

}

Lazarus, R , Baos, S, Cappel-Porter, H, Carson-Stevens, A, Clout, MC , Culliford, L, Emmett, SR, Garstang, J, Gbadamoshi, L, Hallis, B, Harris, RA, Hutton, D & Group, CT 2021, The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV).. https://doi.org/10.2139/ssrn.3931758

TY - GEN

T1 - The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

AU - Lazarus, R

AU - Baos, S

AU - Cappel-Porter, H

AU - Carson-Stevens, A

AU - Clout, MC

AU - Culliford, L

AU - Emmett, SR

AU - Garstang, J

AU - Gbadamoshi, L

AU - Hallis, B

AU - Harris, RA

AU - Hutton, D

AU - Group, CT

PY - 2021/9

Y1 - 2021/9

UR - http://europepmc.org/abstract/PPR/PPR418587

U2 - 10.2139/ssrn.3931758

DO - 10.2139/ssrn.3931758

M3 - Other contribution

ER -

The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

UN SDGs

Access to Document

Handle.net

Other files and links

Cite this